Most patent disputes settle before trial. Learn how companies negotiate entry, avoid costly litigation, and turn patent conflicts into strategic deals - with real data from tech, telecom, and pharma industries.
Continue Reading
Patent litigation in the generic drug market is delaying affordable medicines, costing billions annually. Learn how the Hatch-Waxman Act, Orange Book listings, and serial lawsuits block competition-and what’s being done to fix it.
Continue Reading
